In addition to degrading its primary substrate, GM1 ganglioside, the beta‐galactosidase enzyme can also act on Gal‐Cer [4, 5], which could explain why Gal‐Cer does not accumulate in the nervous system of patients with Krabbe disease (KD) [1, 2]. This evidence concerns the gene CBLN1 and Krabbe disease.